Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Glaucoma Therapeutics Market to reach USD XXX billion by the end of 2029

Global Glaucoma Therapeutics Market Size study & Forecast, by Drug Class (Beta Blockers, Prostaglandins Analogs, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs), By Disease Indication (Open Angle Glaucoma, Angle Closure Glaucoma) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Regional Analysis, 2022-2029

Product Code: HLSDT-28948067
Publish Date: 25-01-2023
Page: 200

Global Glaucoma Therapeutics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Glaucoma therapeutics refers to the various alternative treatments for Primary Angle-Closure (PAC) and Primary Open-Angle (POA) glaucoma. The condition is caused by structural changes in the optic nerves, which frequently lead to blindness and vision loss. Topical eye drops that primarily include beta-blockers, prostaglandin analogues, cholinergic, carbonic anhydrase inhibitors, and alpha-adrenergic agonists can be used to start the treatment for glaucoma. These eye drops decrease the amount of fluid generated in the eyes, reducing intraocular pressure (IOP). The usage of devices such as implantable extended-release devices, drug-eluting punctal plugs, polymer-based contact lenses, microneedle-injection devices, and microdosing technologies can then be followed by traditional or laser surgical procedures or a combination of both. One of the main factors fueling the market’s growth is the rising incidence of glaucoma worldwide. Patients with diabetes and other eye conditions, such as Age-Related Macular Degeneration (AMD), cataract, and dry eye, are significantly more probable to develop glaucoma. Also, another factor driving the market growth is increasing technological advancements in the field of ophthalmology and rising product innovation and development is anticipated to create demand for the market.

The key factors projected to fuel the growth of the global glaucoma therapeutics market are the rising occurrences of blindness and the rising numbers of glaucoma patients. The International Agency for the Prevention of Blindness reports that in 2020, 80 million individuals have glaucoma, an increase of nearly 20 million from its 2010 data findings. Additionally, the rising geriatric population is anticipated to create a lucrative opportunity for the market during the forecast period. However, the drug recalls by major players stifled market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Glaucoma Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the well-developed medical infrastructure and rising prevalence of glaucoma in the region. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as the rising prevalence of diabetes, rising ocular disorders, and the growing number of blind and visually impaired people would create lucrative growth prospects for the Glaucoma Therapeutics market across Asia Pacific region.

Major market player included in this report are:
Deep Dive
Allergan Plc
Merck & Co., Inc.
Akorn Operating Company LLC
Bausch & Lomb Incorporated
Oculis S.A.
Teva Pharmaceuticals Industries Ltd
Alcon
Pfizer Inc.
Nanodropper, Inc.

Recent Developments in the Market:
 In May 2020, AbbVie Inc announced the acquisition of Allergan Plc. Through this AbbVie Inc. has been able to establish itself as a market leader in the glaucoma sector.
 In Dec. 2019, In Japan, Senju Pharmaceutical Co., Ltd. announced the launch of AIBETA, a combination drug for the treatment of glaucoma and hypertension.

Global Glaucoma Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Disease Indication, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:
Beta Blockers
Prostaglandins Analogs
Alpha Adrenergic Agonists
Carbonic Anhydrase Inhibitors
Combination Drugs
By Disease Indication:
Open Angle Glaucoma
Angle Closure Glaucoma
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Glaucoma Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Glaucoma Therapeutics Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Glaucoma Therapeutics Market, by Disease Indication, 2019-2029 (USD Billion)
1.2.4. Glaucoma Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Glaucoma Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Glaucoma Therapeutics Market Dynamics
3.1. Glaucoma Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising incidence of glaucoma
3.1.1.2. Increasing technological advancements
3.1.2. Market Challenges
3.1.2.1. Drug recalls by major players
3.1.3. Market Opportunities
3.1.3.1. Rising geriatric population
Chapter 4. Global Glaucoma Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Glaucoma Therapeutics Market, by Drug Class
6.1. Market Snapshot
6.2. Global Glaucoma Therapeutics Market by Drug Class, Performance – Potential Analysis
6.3. Global Glaucoma Therapeutics Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Glaucoma Therapeutics Market, Sub Segment Analysis
6.4.1. Beta Blockers
6.4.2. Prostaglandins Analogs
6.4.3. Alpha Adrenergic Agonists
6.4.4. Carbonic Anhydrase Inhibitors
6.4.5. Combination Drugs
Chapter 7. Global Glaucoma Therapeutics Market, by Disease Indication
7.1. Market Snapshot
7.2. Global Glaucoma Therapeutics Market by Disease Indication, Performance – Potential Analysis
7.3. Global Glaucoma Therapeutics Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
7.4. Glaucoma Therapeutics Market, Sub Segment Analysis
7.4.1. Open Angle Glaucoma
7.4.2. Angle Closure Glaucoma
Chapter 8. Global Glaucoma Therapeutics Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Glaucoma Therapeutics Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Glaucoma Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Glaucoma Therapeutics Market, Sub Segment Analysis
8.4.1. Hospital Pharmacy
8.4.2. Retail Pharmacy
8.4.3. Online Pharmacy
Chapter 9. Global Glaucoma Therapeutics Market, Regional Analysis
9.1. Glaucoma Therapeutics Market, Regional Market Snapshot
9.2. North America Glaucoma Therapeutics Market
9.2.1. U.S. Glaucoma Therapeutics Market
9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
9.2.1.2. Disease Indication breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Glaucoma Therapeutics Market
9.3. Europe Glaucoma Therapeutics Market Snapshot
9.3.1. U.K. Glaucoma Therapeutics Market
9.3.2. Germany Glaucoma Therapeutics Market
9.3.3. France Glaucoma Therapeutics Market
9.3.4. Spain Glaucoma Therapeutics Market
9.3.5. Italy Glaucoma Therapeutics Market
9.3.6. Rest of Europe Glaucoma Therapeutics Market
9.4. Asia-Pacific Glaucoma Therapeutics Market Snapshot
9.4.1. China Glaucoma Therapeutics Market
9.4.2. India Glaucoma Therapeutics Market
9.4.3. Japan Glaucoma Therapeutics Market
9.4.4. Australia Glaucoma Therapeutics Market
9.4.5. South Korea Glaucoma Therapeutics Market
9.4.6. Rest of Asia Pacific Glaucoma Therapeutics Market
9.5. Latin America Glaucoma Therapeutics Market Snapshot
9.5.1. Brazil Glaucoma Therapeutics Market
9.5.2. Mexico Glaucoma Therapeutics Market
9.5.3. Rest of Latin America Glaucoma Therapeutics Market
9.6. Rest of The World Glaucoma Therapeutics Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Deep Dive
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Allergan Plc
10.2.3. Merck & Co., Inc.
10.2.4. Akorn, Operating Company LLC
10.2.5. Bausch & Lomb Incorporated
10.2.6. Oculis S.A.
10.2.7. Teva Pharmaceuticals Industries Ltd
10.2.8. Alcon
10.2.9. Pfizer Inc
10.2.10. Nanodropper, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now